Company profile: Prestwick Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of therapeutic pharmaceutical drugs for chronic central nervous system diseases, offering products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea. Founded in 2002 and based in Washington, District of Columbia.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Prestwick Pharmaceuticals
Vitro Biopharma
HQ: United States
Website
- Description: Provider of stem cell therapy, cell lines, and cell culture media, including AlloRx Stem Cell therapy from Wharton’s jelly–derived MSCs for autoimmune and inflammatory disorders; MSC-Gro specialty media for MSC growth and expansion; research-grade cancer-associated and native fibroblasts; human umbilical cord and placenta-derived MSC lines; and MSC-Gro formulations (low serum, serum-free, CAF-specific).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vitro Biopharma company profile →
U.S. WorldMeds
HQ: United States
Website
- Description: Provider of specialty pharmaceutical therapies: IWILFIN, an oral maintenance therapy reducing relapse risk in high-risk neuroblastoma after prior treatment response; ZIMHI, a high-dose naloxone injection for emergency treatment of opioid overdose, effective against powerful synthetic opioids like fentanyl; and LUCEMYRA, an oral drug that mitigates opioid withdrawal to facilitate abrupt discontinuation in adults.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full U.S. WorldMeds company profile →
Titan Pharmaceuticals
HQ: United States
Website
- Description: Provider of proprietary therapeutics and subdermal implant drug delivery solutions targeting serious medical disorders. Offerings include ProNeura, a continuous, long-term subdermal delivery platform for chronic conditions; Probuphine, a buprenorphine implant for maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less of oral buprenorphine daily; and a nalmefene implant to prevent relapse after detoxification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Titan Pharmaceuticals company profile →
Link Medicine
HQ: United States
Website
- Description: Provider of research aimed at creating disease-modifying therapies for neurodegenerative diseases, including Alzheimer's and Parkinson's disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Link Medicine company profile →
Magnus Medical
HQ: United States
Website
- Description: Provider of closed-loop neuromodulation technology for intractable neurological and psychiatric disorders. Offers the SAINT Neuromodulation System, a non-invasive magnetic stimulation treatment targeting brain areas associated with depression and delivered over five days, and the Open Label Optimization (OLO) clinical research program evaluating SAINT's effectiveness in Major Depressive Disorder.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magnus Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Prestwick Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Prestwick Pharmaceuticals
2.2 - Growth funds investing in similar companies to Prestwick Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Prestwick Pharmaceuticals
4.2 - Public trading comparable groups for Prestwick Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →